ATAI Life Sciences

Clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders. The company researches both psychedelic and non-psychedelic compounds to develop disease-modifying treatments, setting it apart from traditional pharmaceutical approaches. ATAI Life Sciences primarily targets individuals suffering from mental health conditions, aiming to address significant unmet needs in mental health care.